Local medical device maker ResMed is adjusting its executive leadership assignments and cutting back its workforce to accommodate a shift in strategy. The San Diego-based company is pushing to improve its current product marketing and digital health offerings for the future. Since the 1980s, ResMed has been a leader in health technology for treating patients with obstructive sleep apnea and other respiratory conditions. Urvashi Tyagi, ResMed’s chief technology officer since February 2022, will serve as an adviser into the new year and a consultant through next year. Part of this connects to a number of acquisitions in the digital health and respiratory care space that ResMed has made since 2021.
